Zyla life sciences (EGLT)
Income statement / Yearly
Dec'19Dec'18Dec'17Dec'16Dec'15Dec'14Dec'13Dec'12
Revenue
Net product sales

-

-

-

16,864

4,184

-

-

-

Related party revenue

-

-

-

-

18,646

1,920

-

-

Collaboration revenues

-

-

-

100

-

-

-

-

Revenue

79,527

30,353

26,136

16,964

22,830

1,920

-

1,201

Costs and Expenses
Cost of sales (excluding amortization of product rights)

40,553

7,447

5,153

-

-

-

-

-

Amortization of product rights

12,823

2,107

2,082

-

-

-

-

-

Cost of sales (excluding amortization of product rights)

-

-

-

3,660

3,271

-

-

-

Amortization of product rights

-

-

-

2,006

1,958

-

-

-

General and administrative

22,321

24,079

34,065

30,670

26,474

15,715

5,095

2,241

Sales and marketing

32,536

33,730

35,532

27,892

16,289

946

-

-

Research and development

22

3,536

14,744

33,759

27,054

22,395

6,280

4,256

Restructuring and other charges

1,920

17,043

2,760

-

-

-

-

-

Change in fair value of contingent consideration payable

4,983

-

-

-

-

-

-

-

Total costs and expenses

115,158

87,942

-

-

-

-

-

-

Total costs and expenses

-

-

94,336

97,987

75,046

39,056

11,375

6,497

Loss from operations

-35,631

-57,589

-68,200

-81,023

-52,216

-37,136

-11,375

-5,296

Other (income) expense:
Change in fair value of warrant and derivative liability

-

12,292

2,546

644

260

-

-

-

Interest expense (income), net

-13,353

-41,280

-17,666

-12,109

-7,477

-7,079

-8,842

-75

Other gain, net

3,337

144

750

797

864

1,045

-

-

Gain on extinguishment of debt

-

-

13,221

-

-

-

-

-

Other (gain) loss

-

-

-

-

-

-

222

-

Loss on foreign currency exchange

-

1

-10

-2

-82

3

-190

-27

Total other expense (income)

-10,016

-28,843

-1,159

-10,670

-6,435

-6,031

-8,810

-102

Reorganization items

993

9,022

-

-

-

-

-

-

(Loss) income after reorganization charges and before provision (benefit) for income taxes

-

-

-69,359

-91,693

-58,651

-43,167

-

-

Loss before provision (benefit) for income taxes

-

-

-

-

-

-

-20,185

-5,398

Provision (benefit) for income taxes

-

-

-

-1,061

-718

47

22

-

Net (loss) income

-46,640

-95,454

-69,359

-90,632

-57,933

-43,214

-20,207

-5,398

Per share information:
Net (loss) income per share of common stock—basic and diluted (in dollars per share)

-3.25

-1.81

-2.05

-3.70

-2.94

-2.97

-15.64

-4.18

Weighted-average shares outstanding, basic and diluted (in shares)

14,333

52,775

33,755

24,514

19,738

14,556

1,292

1,292